Pyridopyrimidine compounds and their uses
AssigneeCell Therapeutics, Inc.
InventorsMarc J. McKennon, J. Peter Klein, Michael Coon
Life of this patent
Estimating the term…
Abstract
Novel pyridopyrimidine-based compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling.
Claims36
A therapeutic compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the following formula:
- 31
- wherein:
- R1 is selected from a member of the group consisting of hydrogen, hydroxyl, methoxyl, N—OH, acylamino group, cyano group, sulfo, sulfonyl, sulfinyl, sulfhydryl (mercapto), sulfeno, sulfanilyl, sulfamyl, sulfamino, and phosphino, phosphinyl, phospho, phosphono and —NRaRb, wherein each of Ra and Rb may be the same or different and each is selected from the group consisting of hydrogen and optionally substituted:
- C(1-20)alkyl, C(1-20)cycloalkyl, C(1-20)alkenyl, C(1-20)cycloalkenyl, C(1-20)alkynyl, aryl, heteroaryl, and heterocyclic group.
- R2 and R3 are independently selected from a member of the group consisting of halo, thio, oxo, C(1-20)alkyl, C(1-20)hydroxyalkyl, C(1-20)thioalkyl, C(1-20)alkylthio, C(1-20)alkylamino, C(1-20)alkylaminoalkyl, C(1-20)aminoalkyl, C(1-20)aminoalkoxyalkenyl, C(1-20)aminoalkoxyalkynyl, C(1-20)diaminoalkyl, C(1-20)triaminoalkyl, C(1-20)tetraminoalkyl, C(1-20)aminotrialkoxyamino, C(1-20)alkylamido, C(1-20)alkylamidoalkyl, C(1-20)amidoalkyl, C(1-20)acetamidoalkyl, C(1-20)alkenyl, C(1-20)alkynyl, C(1-20)alkoxyl, C(1-20)alkoxyalkyl, C(1-20)dialkoxyalkyl, and —NRaRb.
- R4 may be hydrogen or an optionally substituted member of the group consisting of C(1-20)alkyl, C(1-20)cycloalkyl, C(1-20)alkenyl, C(1-20)cycloalkenyl, C(1-20)alkynyl, aryl, heteroaryl, and heterocyclic group.
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 32
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 33
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 34
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 35
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 36
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 37
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 38
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 39
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 40
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the formula:
- 41
Dependencies are inferred from the claim text.